NIH-funded research R21 grant

How mRNA localization affects mitochondrial function in neurodegenerative diseases

Official title: mRNA localization as a driver of mitochondrial dysfunction during neurodegeneration

Funded at University of California, San Diego · NIH-10885700 · Data updated 2026-11-12

This study is looking at how the way certain messages in our cells are sent to the mitochondria affects their health, especially in diseases like Alzheimer's, and it hopes to find new ways to help improve treatment for people dealing with these age-related conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startApril 15, 2024
Project endMarch 31, 2026
Funding year2024
Award (this year)$391,668
NIH project number1R21AG087396-01
Project IDNIH-10885700 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with age-related neurodegenerative diseases, particularly those with Alzheimer's disease.

Less likely to help

Patients with non-neurodegenerative conditions or those without cognitive impairment may not benefit from this research.

What this research studies

This research investigates the role of mRNA localization in the mitochondria and how it contributes to mitochondrial dysfunction in neurodegenerative diseases like Alzheimer's. The study aims to understand how the improper targeting of mitochondrial proteins leads to mitochondrial fragmentation, a common issue in these diseases. By exploring the mechanisms behind this process, the research seeks to identify potential therapeutic targets that could help restore mitochondrial function. Patients may benefit from insights gained that could lead to new treatments for age-related neurodegenerative conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve mitochondrial function and slow the progression of neurodegenerative diseases.

How similar studies have gone: Previous research has shown that targeting mitochondrial fragmentation can be protective in models of neurodegenerative diseases, indicating a promising avenue for further exploration.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Zid, Brian Matthew — University of California, San Diego
  • Study coordinator: Zid, Brian Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.